HAE R&D Expenses
Haemonetics Corp · R&D Expenses
HAE R&D Expenses
Latest reported$59.46Mperiod ending
HAE TTM R&D Expenses ($0.00 → $59.46M)
TTM R&D Expenses
High-resolution chart · PNG
HAE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 59,456,000 | |
| 59,517,000 | |
| 61,030,000 | |
| 62,572,000 | |
| 62,188,000 | |
| 60,376,000 | |
| 68,874,000 | |
| 66,310,000 | |
| 64,836,000 | |
| 63,035,000 | |
| 62,722,000 | |
| 62,146,000 | |
| 60,377,000 | |
| 58,631,000 | |
| 56,097,000 | |
| 53,445,000 | |
| 53,402,000 | |
| 55,201,000 | |
| 52,234,000 | |
| 49,698,000 | |
| 45,608,000 | |
| 40,657,000 | |
| 39,188,000 | |
| 38,687,000 | |
| 39,346,000 | |
| 39,083,000 | |
| 30,656,000 | |
| 32,634,000 | |
| 33,795,000 | |
| 35,714,000 | |
| 38,054,000 | |
| 41,503,000 | |
| 40,441,000 | |
| 39,228,000 | |
| 47,162,000 | |
| 43,197,000 | |
| 44,012,000 | |
| 47,256,000 | |
| 50,284,000 | |
| 52,764,000 | |
| 55,981,000 | |
| 55,865,000 | |
| 51,041,000 | |
| 50,742,000 | |
| 50,127,000 | |
| 54,188,000 | |
| 50,799,000 | |
| 54,365,000 | |
| 58,373,000 | |
| 54,200,000 | |
| 58,182,000 | |
| 54,561,000 | |
| 50,442,000 | |
| 48,642,000 | |
| 39,435,000 | |
| 38,079,000 | |
| 37,602,000 | |
| 36,802,000 | |
| 36,977,000 | |
| 35,741,000 | |
| 33,345,000 | |
| 32,656,000 | |
| 30,532,000 | |
| 28,997,000 | |
| 27,518,000 | |
| 26,375,000 | |
| 26,671,000 | |
| 26,050,000 | |
| 24,792,000 | |
| 23,859,000 | |
| 22,691,000 | |
| 22,380,000 | |
| 23,890,000 | |
| 24,322,000 | |
| 25,071,000 | |
| 25,346,000 | |
| 24,738,000 | |
| 23,884,000 | |
| 22,574,000 | |
| 26,233,000 | |
| 26,397,000 | |
| 26,516,000 | |
| 26,390,000 | |
| 23,511,000 | |
| 21,481,000 | |
| 19,994,000 | |
| 18,993,000 | |
| 16,481,000 | |
| 16,850,000 | |
| 17,793,000 | |
| 18,521,000 | |
| 19,082,000 | |
| 19,570,000 | |
| 19,512,000 | |
| 9,246,000 | |
| 19,759,000 | |
| 19,637,000 | |
| 19,463,000 | |
| 30,398,000 | |
| 20,456,000 |